| |
|
|
|
AVITA Therapeutics Inc.  
|
|
30 0.64 (0.02%) |
07-02 16:00 |
|
Open: |
29.3 |
Pre close: |
29.36 |
Target:
|
35.87
|
|
High: |
30.38 |
Low: |
29.27 |
Resistance:
|
30.71
35.87
|
|
Volume: |
90,625 |
Market Cap: |
3200M |
Support:
|
14.94
5.20
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
20.24
 |
MACD |
MACD(12,26):
|
4.40 |
|
MA(20): |
9.75 |
Signal(12,26,9): |
1.61 |
|
MA(100): |
7.29 |
Stochastic Oscillator |
%K(14,3):
|
97.09 |
|
MA(250): |
7.55 |
%D(3): |
76.86 |
|
Average Volume(K) |
3-Month: |
37363
|
52-Week |
High:
|
30.71 |
|
10-Days: |
48011 |
Low: |
4.00 |
|
RSI |
RSI(14):
|
90.01 |
Change(%): |
399.2 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-52.3 |
Shares Out. (M) |
106.67 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-29.9 |
Shares Float (M) |
84.78 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
434.1 |
% Held by Institutions |
11.23 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
0.056 |
Shares Short (K) |
549 |
|
Book Value (p.s.) |
0.000 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.00 |
|
Profit Margin |
-260.40 |
Operating Cash Flow
(M) |
0.00 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
0.00 |
|
|
|
|
|
|
